来源:环球市场播报
诺和诺德(NVO)周二早盘上涨4.8%。该公司昨日宣布在美国推出口服版Wegovy,现金自付价格起价为每月149美元,并通过大型药房和远程医疗扩大分销渠道,而礼来公司(LLY)也正准备推出竞品口服药。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.